IHH Healthcare's outlook appears positive, given its robust expansion plan, Public Investment Bank analyst Thye May Ting says in a note. This includes its acquisition of Island Hospital, which is projected to deliver over MYR200 million in synergies over the next five years, she says. IHH's focus on organic and inorganic expansion, along with optimizing assets that are underperforming, positions the company well for future growth, she notes. Its efforts to enhance efficiency through digitization and value-based healthcare initiatives could equip IHH to navigate macroeconomic challenges, she adds. Public IB raises IHH's target price to MYR8.64 from MYR7.68, while maintaining an outperform rating on the stock. Shares are 0.1% lower at MYR7.22.(yingxian.wong@wsj.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。